Figure 6 depicts the key questions (KQs) within the context of the PICO (population, interventions, comparators, and outcomes) described elsewhere in this document. In general, the figure shows that KQs 1-3 and 6 focus on ovarian cancer outcomes, KQ 4 on benefits of OC use and KQ 5 on harms of OC use. KQ 7, research gaps, is not shown in the analytic framework.

Figure 6Analytic framework for systematic review

BRCA = breast cancer (genetic mutation); K = Key Question; OC = oral contraceptive

Note: KQ 7 is not shown in the analytic framework.

From: 1, Introduction and Methods

Cover of Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer
Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer.
Evidence Reports/Technology Assessments, No. 212.
Havrilesky LJ, Gierisch JM, Moorman PG, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.